The scale of the alliance also emphasises once again how China has become a pacesetter for biopharma R&D, with a Goldman Sachs report recently estimating that around 46% of all new drug molecules that began human trials in the first half of 2025 originated in Chinese biopharma companies, up from 17% a decade ago
R., Mavros, P., Hansen, M., & Herrstedt, J
Depending on your requirements, each dose may contain 2 ml of the drug
Tirzepatide represents a breakthrough in weight loss medication, combining GLP-1 and GIP receptor agonism to target multiple metabolic pathways simultaneously
E., Liu, F., Cao, Q., Swago, S., Jacobs, P
The settlement comes amid a broader national reckoning over ethylene oxide use